RIGL - RIGEL PHARMACEUTICALS INC

QQQ $ 442.84 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.28 $ -2.45 (-1.12 %)

Previous Close

$ 0.9822

Open

$ 0.97

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.96 - $ 0.99

52 Week Range

$ 0.71 - $ 1.96

Volume

708,629

Average Volume

Market Cap

172.08M

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-05-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-01-2023	06-30-2023	10-Q
5	05-02-2023	03-31-2023	10-Q
6	03-07-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-02-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-05-2021	03-31-2021	10-Q
14	03-02-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-04-2020	06-30-2020	10-Q
17	05-05-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-01-2018	03-31-2018	10-Q
26	03-06-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-01-2017	06-30-2017	10-Q
29	05-02-2017	03-31-2017	10-Q
30	03-07-2017	12-31-2016	10-K
31	11-01-2016	09-30-2016	10-Q
32	08-02-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	03-08-2016	12-31-2015	10-K
35	11-03-2015	09-30-2015	10-Q
36	08-04-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	03-03-2015	12-31-2014	10-K
39	11-04-2014	09-30-2014	10-Q
40	08-05-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Rige...
05/08/2024 13:37:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15...

Rigel Pharmaceuticals Q1 2024 GAAP EPS $(0...
05/07/2024 20:40:41

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

Rigel Publishes Data On REZLIDHIA In Post-...
04/04/2024 12:11:03

Olutasidenib induced durable composite complete remission in 43.8% of patients relapsed or refractory to prior venetoclax-based...

Citigroup Maintains Buy on Rigel Pharmaceu...
03/07/2024 14:30:43

Citigroup analyst Yigal Nochomovitz maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target fro...

Cantor Fitzgerald Maintains Neutral on Rig...
03/06/2024 17:34:17

Cantor Fitzgerald analyst Kristen Kluska maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price t...

HC Wainwright & Co. Reiterates Buy on Rige...
03/06/2024 13:55:22

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15...

B. Riley Securities Maintains Neutral on R...
03/06/2024 13:37:03

B. Riley Securities analyst Kalpit Patel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and maintains $1.25 pr...

Rigel Pharmaceuticals: Q4 Earnings Insights
03/05/2024 21:15:05

Rigel Pharmaceuticals Q4 Sales $35.792M Be...
03/05/2024 21:14:42

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly sales of $35.792 million which beat the analyst consensus estimate of $3...

Earnings Scheduled For March 5, 2024
03/05/2024 10:00:02

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

Earnings Outlook For Rigel Pharmaceuticals
03/04/2024 18:03:20

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
02/23/2024 13:06:12

HC Wainwright & Co. Reiterates Buy on Rige...
02/22/2024 17:27:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15...

Rigel Pharmaceuticals Acquires U.S. Rights...
02/22/2024 12:53:21

GAVRETO® (pralsetinib) is an FDA approved targeted therapy for the treatment of RET fusion-positive metastatic non-small cell l...

Rigel Pharmaceuticals Sees Prelim. Q4 Reve...
01/08/2024 13:18:26

HC Wainwright & Co. Reiterates Buy on Rige...
01/04/2024 15:27:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15...

Rigel Announces CONNECT Collaboration To C...
01/04/2024 13:11:55

Under the collaboration, CONNECT will include olutasidenib in CONNECT's TarGeT-D, a molecularly guided Phase 2 umbrella cli...

HC Wainwright & Co. Reiterates Buy on Rige...
12/08/2023 14:44:46

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15...

Rigel Pharmaceuticals Announced A Multi-ye...
12/08/2023 13:06:33

Rigel and MD Anderson will jointly lead all clinical development efforts, which will be overseen by a joint steering committee....